PhRMA RECOMMENDS CHANGES TO PART 11

Drug GMP Report
KEYWORDS FDA / Part 11
A A

PhRMA is urging the FDA to withdraw or scale back its Part 11 regulation in favor of other more recently approved legislation addressing electronic records, arguing that the rule is too prescriptive and the cost of compliance too high.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $10.00